1rtl: Difference between revisions

@@ Line 1: / Line 1: @@
-[[Image:1rtl.gif|left|200px]]
+{{Seed}}
+[[Image:1rtl.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_1rtl|  PDB=1rtl  |  SCENE=  }}
-'''CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN: NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND PYRROLIDINE-5,5-TRANSLACTAM INHIBITOR'''
+===CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN: NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND PYRROLIDINE-5,5-TRANSLACTAM INHIBITOR===
-==Overview==
+<!--
-[reaction: see text] In this, the first of two Letters, we describe how a P3/P4 urea linking unit was used to greatly enhance the biochemical and replicon potency of inhibitors based upon the pyrrolidine-5,5-trans-lactam template. Compound 7b demonstrated a 100 nM IC(50) in the replicon cell-based surrogate HCV assay.
+The line below this paragraph, {{ABSTRACT_PUBMED_14627400}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 14627400 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_14627400}}
 ==About this Structure==
@@ Line 31: / Line 35: @@
 [[Category: Translactam]]
 [[Category: Viral protein]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 07:53:27 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 08:58:57 2008''

Navigation menu